Ownership history in Commodore Capital LP · 3 quarters on record
This page tracks every 13F SEC filing in which Commodore Capital LP reported a position in AGIOS PHARMACEUTICALS INC (AGIO). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | ADDED | 2,338,287 | +13,287 | +0.6% | 4.58% | $93.9M | $40.14 |
| 2025 Q2 | ADDED | 2,325,000 | +140,000 | +6.4% | 5.46% | $77.3M | $33.26 |
| 2025 Q1 | INITIATED | 2,185,000 | — | — | 4.72% | $64.0M | $29.30 |
As of 2025 Q4 — sorted by position size